The overwhelming majority of people who supposedly test “positive” for the Wuhan coronavirus (COVID-19) are actually virus-free, according to The New York Times.
As it turns out, the PCR tests that millions of scared Americans have been hoodwinked into getting are a sham. They only pick up partial viral fragments rather than whole viruses, and are hardly the “gold standard” that proponents claim they are.
While the Times says that PCR tests are “diagnosing huge numbers of people who may be carrying relatively insignificant amounts of the virus,” the fact of the matter is that PCR tests are diagnosing huge numbers of people who have none of the virus at all.
Testing data from Massachusetts, New York, Nevada, and elsewhere shows that upwards of 90 percent of people who test positive for the Wuhan coronavirus (COVID-19) are not actually infected with it.
Since the Times is largely whitewashing the news by suggesting that the so-called pandemic is still serious and worrisome, we can only surmise that even this 90 percent figure is too low. Michael Thau, writing for Red State, agrees.
“[T]he research the Times cites actually suggests that those bogus positive tests they discovered were given to people carrying no virus whatsoever, not just insignificant amounts, as they report,” he explains.
“And [their] upper bound of 90% for bogus positives is likely too low as well.”
Flawed PCR tests have raked in more than $13 billion in corporate profits
The U.S. Centers for Disease Control and Prevention (CDC) is well aware that false positives are a serious problem, claiming that they are being “mistakenly” reported to public health agencies. But the truth is that the tests themselves are a problem, and that is no mistake.
The entire plandemic has been built upon the lie that millions upon millions of people are testing positive for the Wuhan coronavirus (COVID-19) when in reality most of them are healthy people receiving false-positive test results.
These phony PCR tests have also contributed to the misnomer that most supposedly infected patients are “asymptomatic carriers,” which is why they do not appear sick. Again, the reality is that most “positive cases” of the Wuhan coronavirus (COVID-19) are completely fictitious figments of the imagination.
“The massive fraud perpetrated on the American people – who were led to believe that PCR testing represents the ‘gold standard’ for detecting COVID-19 infections – must be one of the biggest scams in history,” Thau writes.
It is a fraud that has made some people very rich, however. At $150 a pop, the more than 85 million PCR tests that have been administered just in the U.S since the Wuhan coronavirus (COVID-19) started dominating media headlines has garnered about $13 billion in profits for test kit manufacturers and testing labs.
Meanwhile, the more than seven million Americans who received fake positive test results have presumably been put through hell believing themselves to be carrying the dreaded China Virus. Some of them likely suffered depression, while others faced job loss, isolation or simply fear and worry that possibly led to other health problems.
Amazingly, the Times is barely reporting any of this, at least not with the same type of rigor that it previously reported on PCR tests being the alleged “gold standard” for Wuhan coronavirus (COVID-19) testing.
“Now it is time for massive class action lawsuits … against big pharma for that scooped up $13 billion and … the soon to be approved fake annual vaccines,” wrote one Red State commenter.
“As in all things, if you want to find the truth, follow the money.”
For more related news about the Wuhan coronavirus (COVID-19) plandemic, be sure to check out Pandemic.news.
Sources for this article include:
- Belgian health experts accuse WHO of faking coronavirus pandemic
- BOMBSHELL: Former Pfizer executive says covid-19 “pandemic is over,” so-called “second wave” based on fraudulent testing
- Doubts raised on effectiveness of coronavirus antibody testing in the UK
- Air travelers hiding coronavirus infections to get into Hong Kong highlight reopening risks